Prosecution Insights
Last updated: October 01, 2026
Application No. 18/392,020

RADIOPAQUE INK FORMULATIONS CONTAINING NANOPARTICLES AND USES THEREOF

Non-Final OA §103
Filed
Dec 21, 2023
Priority
Dec 23, 2022 — provisional 63/435,086
Examiner
COHEN, STEFANIE J
Art Unit
Tech Center
Assignee
Walmart Apollo LLC
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
78%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
740 granted / 981 resolved
+15.4% vs TC avg
Minimal +2% lift
Without
With
+2.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
42 currently pending
Career history
999
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
59.6%
+19.6% vs TC avg
§102
10.9%
-29.1% vs TC avg
§112
20.0%
-20.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 981 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1-12, in the reply filed on 7/24/26 is acknowledged. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-3 are rejected under 35 U.S.C. 103 as being unpatentable over Li et al (20090281558). Li teaches surgical meshes with radiopaque coatings. Li, abstract, teaches implantable medical articles which comprise a surgical mesh that is at least partially covered with a coating that comprises a radiopaque material such as a metal or a metallic compound. The radiopaque material is present in the coating in an amount such that the coated portions of the mesh are visible using radiographic imaging techniques. Li, paragraph 15 of the PGPUB, teaches the radiopaque material may be present in the coating in an amount such that the coated portions of the mesh are visible under x-ray fluoroscopy. Li, paragraph 19 of the PGPUB, teaches the coating may comprise gold. Li, paragraph 23 of the PGPUB, teaches at least one dimension may range, for example, from 100 microns to 50 microns to 25 microns to 10 microns to 5 microns to 2 microns to 1 micron to 1000 nm to 500 nm to 250 nm to 100 nm to 50 nm to 25 nm to 10 nm or less. Li, paragraph 42 of the PGPUB, teaches coatings are applied in the form of a fluid. A 20 nm gold nanoparticle contains about 247,000-250,000 gold atoms. Regarding claim 2, Li, paragraph 42 of the PGPUB, teaches coatings are applied in the form of a fluid (e.g., a solution, dispersion, melt, etc.) using a suitable application technique, which may be selected, for example, from techniques in which fluid is selectively applied to only to certain regions of the mesh, for example, through the use of a suitable application device such as a printer (e.g., screen printing device, ink jet printer, etc.). It would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains to choose a viscosity on the coating so that it can be applied effectively with an ink jet printer. Regarding claim 3, Li teaches surgical mesh that is at least partially covered with a coating that comprises a radiopaque material such as a metal or a metallic compound. The mesh as taught by Li reads on a substrate as claimed in claim 3. The mesh coated with the coating as taught by Li reads on a label as claimed in claim 3. Claims 4-10 and 12 are rejected under 35 U.S.C. 103 as being unpatentable over Li et al (20090281558) as applied to claim 1 and further in view of Watanabe et al (20100054404). Although Li teaches the radiopaque material is present in the coating in an amount such that the coated portions of the mesh are visible using radiographic imaging techniques, Li does not teach a specific technique. Watanabe, paragraphs 32-33 of the PGPUB, teaches the X-ray imaging apparatus 80 includes an X-ray generator 81, an X-ray image detector 10, a control unit 82, and a display unit (monitor) 83. The X-ray generator (i.e., radiation generator) 81 emits radiation (X-rays) toward an object (e.g., human body). The X-ray image detector 10 shoots an X-ray image based on the object by detecting the radiation emitted by the X-ray generator 81 and transmitted through the object. The control unit 82 collectively controls processing of the X-ray imaging apparatus 80. For example, the control unit 82 controls radiographic imaging (X-ray imaging) by the X-ray generator 81 and the X-ray image detector 10. The control unit 82 also controls read drive of the X-ray image detector 10 and image transfer. The display unit 83 displays the X-ray image of the object shot by the X-ray image detector 10. It would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains to use this apparatus (system) as taught by Watanabe as the technique as taught by Li as Watanabe teaches this radiographic imaging apparatus is capable of realizing both convenience when portably using a detector and high performance when stationarily using the detector and a control method thereof. Regarding claims 5-6, Li teaches one mesh can comprise a silver coating and other mesh can comprise a gold coating. It would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains that these meshes can be arranged in front or in back of one another as they will have different radiodensities and therefore they will appear differently on x-rays. Regarding claim 7, Li, paragraph 36 of the PGPUB, teaches a popular treatment of stress urinary incontinence (SUI) is via the use of a surgical mesh, commonly referred to as a sling, which is placed under a patient's bladder neck or mid-urethra to provide a urethral platform. Li, paragraph 38 of the PGPUB, teaches as with SUI, treatment of pelvic floor disorders are commonly treated by implanting a surgical mesh within the patient's pelvis to support the organ or organs that require support. Regarding claim 8, Watanabe, paragraph 13 of the PGPUB, teaches a radiographic imaging apparatus capable of realizing both convenience when portably using a detector and high performance when stationarily using the detector and a control method thereof. Li teaches surgical meshes with radiopaque coatings which are considered a consumer product. Regarding claim 9, Watanabe, paragraph 13 of the PGPUB, teaches a radiographic imaging apparatus capable of realizing both convenience when portably using a detector and high performance when stationarily using the detector and a control method thereof which is associated with a point of sale terminal or an autonomous robot in the retail facility as claimed in claim 9. Li teaches surgical meshes with radiopaque coatings which are considered a consumer product in a retail facility as claimed in claim 9. Regarding claim 10, Li teaches surgical meshes with radiopaque coatings. Regarding claim 12, it would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains to have a database of x-ray images to compare the x-ray images as taught by the references to the database images. Claim 11 is rejected under 35 U.S.C. 103 as being unpatentable over Li et al (20090281558) in view of Watanabe et al (20100054404) as applied to claim 4 and further in view of Rogers et al (20120065503). Although the references teach a surgical mesh that is at least partially covered with a coating, the references do not teach the coating printed on a label which is affixed to the mesh. Rogers teaches an implantable medical device (IMD) may comprise one or more radiopaque articles selected from a predetermined set of radiopaque articles. Rogers, paragraph 4 of the PGPUB, teaches the radiopaque marker may be adhered to, molded into, embedded within, or otherwise affixed to the molded desiccant article. Rogers, paragraph 12 of the PGPUB, teaches carrying the one or more radiopaque articles may comprise embedding the one or more radiopaque articles within a desiccant article or polymer article carried by the IMD and/or affixing the one or more radiopaque articles with an adhesive or a tape. It would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains that the coating as taught by the references can be adhered to the mesh via tape as taught by Rogers as this is one method to adhere radiopaque materials to a surface. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US20050085723 teaches a medical device includes a body comprised substantially of radiolucent material and a radiopaque marker. Any inquiry concerning this communication or earlier communications from the examiner should be directed to STEFANIE J COHEN whose telephone number is (571)270-5836. The examiner can normally be reached 10am- 6pm M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Coris Fung can be reached at (571) 270-5713. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /STEFANIE J COHEN/Examiner, Art Unit 1732 9/16/26
Read full office action

Prosecution Timeline

Dec 21, 2023
Application Filed
Sep 17, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12747361
Improved Non-Stick Coating
3y 10m to grant Granted Sep 29, 2026
Patent 12729120
Compound
2y 11m to grant Granted Sep 08, 2026
Patent 12722983
ACID TREATMENT OF LiNiO2 TO DECREASE GAMMA-NiOOH FORMATION
2y 8m to grant Granted Sep 01, 2026
Patent 12722971
HYDROGEN PRODUCTION SYSTEM
2y 8m to grant Granted Sep 01, 2026
Patent 12703796
STEROL IN ASPHALT ROOFING MATERIALS
4y 7m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
78%
With Interview (+2.5%)
2y 9m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 981 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month